Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation.

EMBO Reports
Noritaka YasudaIssei Komuro

Abstract

The angiotensin II type 1 (AT(1)) receptor is a G protein-coupled receptor that has a crucial role in the development of load-induced cardiac hypertrophy. Here, we show that cell stretch leads to activation of the AT(1) receptor, which undergoes an anticlockwise rotation and a shift of transmembrane (TM) 7 into the ligand-binding pocket. As an inverse agonist, candesartan suppressed the stretch-induced helical movement of TM7 through the bindings of the carboxyl group of candesartan to the specific residues of the receptor. A molecular model proposes that the tight binding of candesartan to the AT(1) receptor stabilizes the receptor in the inactive conformation, preventing its shift to the active conformation. Our results show that the AT(1) receptor undergoes a conformational switch that couples mechanical stress-induced activation and inverse agonist-induced inactivation.

References

Aug 1, 1995·Circulation Research·T YamazakiK Tobe
May 26, 1995·The Journal of Biological Chemistry·Y H FengS S Karnik
Jan 1, 1993·Annual Review of Physiology·I Komuro, Y Yazaki
Mar 6, 1999·The Journal of Biological Chemistry·S MiuraS S Karnik
Jul 20, 2001·Trends in Pharmacological Sciences·G VauquelinP Vanderheyden
May 2, 2002·The Journal of Biological Chemistry·Shin-Ichiro Miura, Sadashiva S Karnik
Nov 26, 2002·The Journal of Biological Chemistry·Shin-ichiro MiuraSadashiva S Karnik
Feb 3, 2004·The Journal of Biological Chemistry·Takanobu TakezakoSadashiva S Karnik
Jan 10, 2006·Developmental Cell·A Wayne OrrMartin A Schwartz
Jan 13, 2006·Nature Chemical Biology·Jean-Pierre VilardagaMartin J Lohse
May 13, 2006·The Journal of Biological Chemistry·Shin-ichiro MiuraKeijiro Saku
Jun 27, 2006·Nature Chemical Biology·Xiaojie YaoBrian Kobilka
Oct 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mirianas ChachisvilisJohn A Frangos

❮ Previous
Next ❯

Citations

Dec 7, 2011·European Journal of Applied Physiology·Joseph R Libonati
May 1, 2009·Pflügers Archiv : European journal of physiology·Dimitar P ZankovMinoru Horie
May 22, 2010·Pflügers Archiv : European journal of physiology·Amanda PatelEric Honoré
Apr 28, 2012·Cardiovascular Drugs and Therapy·Hiroshi AkazawaIssei Komuro
Mar 2, 2011·Journal of Cardiovascular Translational Research·Byambajav BuyandelgerRalph Knöll
Oct 5, 2013·Journal of Chemical Information and Modeling·Minos-Timotheos MatsoukasTheodore Tselios
Aug 8, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yingjie QinIssei Komuro
Nov 28, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shin-Ichiro Miura, Keijiro Saku
Jul 30, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masahiro FujinoKeijiro Saku
Oct 12, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Gang LiuAkira Nishiyama
Oct 12, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kouichi TamuraSatoshi Umemura
May 11, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takuya KishiKenji Sunagawa
May 31, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yukako OzasaIssei Komuro
Oct 15, 2008·Nature Clinical Practice. Cardiovascular Medicine·Domenico CorradiOttavio Alfieri
Aug 6, 2008·Nature Reviews. Microbiology·Carol A Kumamoto
Mar 20, 2010·The Journal of Biological Chemistry·Hamiyet UnalSadashiva S Karnik
Jul 8, 2011·Journal of the Royal Society, Interface·Deshun Lu, Ghassan S Kassab
Jun 10, 2010·Science Signaling·Kriti RakeshHoward A Rockman
Apr 17, 2009·American Journal of Physiology. Cell Physiology·Yan-Liang ZhangMirianas Chachisvilis
Apr 11, 2012·International Journal of Vascular Medicine·Hussein M Atta
Jul 7, 2010·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Shin-ichiro MiuraKeijiro Saku
Aug 10, 2011·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Yoshihiro KiyaKeijiro Saku
May 31, 2011·BMC Biology·Merel J W Adjobo-HermansTheodorus W J Gadella
Jan 14, 2012·Vascular Health and Risk Management·Relu CernesReuven Zimlichman
Feb 18, 2014·The Journal of Clinical Investigation·Jason R CookFrancesco Ramirez
Oct 9, 2013·Pflügers Archiv : European journal of physiology·Stephanie BlodowMichael Mederos y Schnitzler
Nov 2, 2013·Pflügers Archiv : European journal of physiology·Imane JemalAna Gomis
Sep 15, 2014·Life Sciences·Dane J YoutzLoren E Wold
Oct 30, 2013·Clinical and Experimental Hypertension : CHE·Shin-ichiro Miura, Keijiro Saku
May 10, 2012·Clinical and Experimental Hypertension : CHE·Joji MoriiKeijiro Saku
Feb 24, 2016·Stem Cells International·Guido KrenningJan-Renier A J Moonen
Jul 31, 2012·Trends in Cardiovascular Medicine·Ralph Knöll, Steve Marston
Dec 15, 2010·Current Opinion in Pharmacology·Michael Mederos y SchnitzlerThomas Gudermann
Nov 17, 2010·Nitric Oxide : Biology and Chemistry·Motohiro NishidaHitoshi Kurose
Jun 9, 2009·Pharmacology & Therapeutics·Ryuji InoueYasuhiro Kawarabayashi
Apr 7, 2009·Journal of Molecular and Cellular Cardiology·Reza Sharif-NaeiniEric Honoré
May 7, 2009·Molecular and Cellular Endocrinology·John HuynhLeonard Keith Pattenden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.